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Abstract
Background: In the past six years, there has been a steady rise in the number of reported cases of
chlamydia and gonorrhea in the United States. Expedited partner therapy (EPT) refers to the
practice of treating partners of patients diagnosed with specific treatable sexually transmitted
infections without first evaluating them. This treatment was recommended by the Centers for
Disease Control and Prevention in 2006 and it is currently legalized in 45 states and the District
of Columbia. However, many health care providers (HCPs) do not have knowledge of EPT
therefore do not make use of it.
Purpose: This quality improvement (QI) project provided education on expedited partner therapy
to providers at a community health center in Maryland. The goal was to increase awareness and
knowledge of expedited partner therapy, and the intention to utilize EPT to improve its use.
Methods: Recruitment of the participants involved providing an overview of the project during
staff meetings followed by sending emails to the clinicians. Pre and post intervention surveys
were sent to clinicians via SurveyMonkey for data collection. The education intervention was
through PowerPoint.
Results: Using the Wilcoxon signed rank test, the intervention resulted in statistically significant
results when current EPT use was compared to future plan to use EPT. Results for most of the
other variables were not statistically significant.
Conclusion: Increase knowledge and awareness of EPT can result in improved use. However, the
outcome for most variables were not statistically significant, but future projects or studies could
use larger samples to determine significance of the other variables.
Keywords: Expedited partner therapy, sexually transmitted infections, chlamydia,
treatment
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Increasing Knowledge and Awareness of Expedited Partner Therapy among Providers

Introduction
Expedited partner therapy (EPT) is the practice of treating partners of patients diagnosed
with sexually transmitted infections (STIs) without first evaluating them (Centers for Disease
Control and Prevention [CDC], 2020). In 2006, EPT was recommended by the CDC for the
management of some treatable STIs (gonorrhea and chlamydia) in the United States (CDC,
2020). Currently, EPT is permissible in 45 states, the District of Columbia, and the
Commonwealth of the Northern Mariana Islands (CDC, 2020). While EPT is potentially
allowable in four states as well as Puerto Rico and Guam, it is prohibited in South Carolina
(CDC, 2020). Due to lack of knowledge of EPT, it is still underutilized by many health care
providers (HCPs) who manage STIs despite legalization in most states.
Background
There has been a steady increase in the number of reported cases of STIs in the United
States. The CDC (2019) reported that in 2018, there were 1.8 million reported cases of
chlamydia, a 19% rate increase since 2014: and 583,405 reported cases of gonorrhea, a 63% rate
increase since 2014. In 2018, Maryland reported 35,482 reported cases of chlamydia, a 28%
overall rate increase between 2014 and 2018 and 10,305 reported cases of gonorrhea, a 66%
increase in the same time period (Maryland Department of Health [MDH], 2019). About 10-15%
of women with untreated chlamydia will develop pelvic inflammatory disease which can lead to
infertility (CDC, 2019). Therefore, the rise in STI cases both at the national and at the state level
needs to be addressed. One option to address the STI burden is through creating awareness and
increasing knowledge of EPT among providers and consequently increase EPT use.
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Expedited partner therapy (EPT) use was recommended by the CDC more than a decade
ago, therefore, there should be more widespread EPT use compared to what is reflected in
practice (CDC, 2020). In Maryland, clinicians including licensed physicians, advanced practice
nurses (APNs), physician assistants (PAs), and registered nurses (RNs) in local health
departments are allowed to prescribe EPT (MDH, 2019). A quality improvement (QI) project
was carried out at a federally qualified health center (FQHC) in Maryland to increase EPT
awareness and knowledge among HCPs. The desired result of this DNP project is an increase in
knowledge and intention to utilize EPT among clinicians at the FQHC.
Problem Statement
The risk of sexually transmitted infections (STIs) in Maryland is indicated by high rates
of treatable STIs, mainly chlamydia and gonorrhea. This is partially due to a lack of knowledge
of EPT which leads to suboptimal utilization of EPT among HCPs despite the legalization of
EPT in 45 states and the District of Columbia (CDC, 2020). Lack of EPT knowledge applies to
many settings including the community health clinics in Maryland.
Organizational “Gap” Analysis of Project Site
The project was carried out at a community health clinic in Maryland. Informal
interaction with the providers at one of the health clinics prior to project implementation revealed
that most of the clinicians do not utilize EPT for patients diagnosed with chlamydia. The clinic
has nurse practitioners as well as physicians in different specialties including
obstetrics/gynecology (Ob/gyn), internal medicine (IM), and family practice (FP). An assessment
conducted in one of the FQHC locations before implementing the project indicated that, although
62.5% of the providers in that location were aware of EPT, only 25% of the providers prescribe
EPT. Further investigation of the organization policies revealed that there is no written policy on
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EPT. The analysis identified a gap in knowledge and policy formulation for EPT use. In addition,
there were gaps in providers’ knowledge of EPT, the legal aspects of EPT, and dispensing
procedures for EPT. Leichliter et al. (2016), emphasized that policies in public health have the
potential to create a positive influence in many individuals’ lives at a relatively low cost. This QI
project was carried out to address the gaps in knowledge of EPT.
Review of Literature
For the literature search, two main databases PubMed and the Cumulative Index of
Nursing and Allied Health Literature (CINAHL) were utilized. The search terms used in the
literature were “expedited partner therapy”, “sexually transmitted infections”, “chlamydia
treatment”. The initial search in CINAHL yielded 102 results, this was narrowed down with the
inclusion criteria of publication date between 2015 and 2020, peer-reviewed articles, full text
only, English only, adults only. The exclusion criteria were meta-analysis, editorials, and articles
published before 2015. The final search yielded 10 articles, from which three articles were
manually selected. Two of the articles were randomized controlled trials (RCTs) and the third
one was an expert opinion report. The Johns Hopkins Nursing Evidence-based Practice guide
was used to select relevant articles based on the level of evidence and quality. The RCTs were
level II evidence, one was grade A because the study was large scale and the results can be
generalized, and the other was grade C because more research was needed to determine
effectiveness. The other one was level IV evidence, grade B because it was based on expert
opinion report.
The PubMed database was accessed with the same search terms used, “expedited partner
therapy”, “sexually transmitted infections”, and “chlamydia treatment”. The inclusion criteria
were, publication date between 2015 and 2020, peer-reviewed articles, full text only, English
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only, adults only. The exclusion criteria used was similar to the one for CINAHL in that metaanalysis, editorials, and articles published before 2015 were eliminated. The search initially
yielded 24 articles, but it was narrowed down by using the term “chlamydia” and eliminating the
word “treatment” from the search terms which yielded 15 articles. A manual selection was done
to obtain seven articles based on the Johns Hopkins Nursing Evidence-based Practice guide for
level of evidence and quality. One of the articles was an RCT, level II evidence, grade A. The
other six were level III evidence, grade B or C because five of them were descriptive studies and
one was a mixed method study. Based on the level of evidence, a total of ten peer reviewed
publications were selected for the basis of this literature review. The information obtained is
substantial to make conclusions about EPT. The report from the literature search is grouped into
two different sections: facilitators and barriers of EPT use.
Facilitators for EPT
A public health program that made free patient delivered partner therapy (PDPT) or free
clinic stocks of EPT could increase awareness of EPT among providers, its distribution, and use
(Golden et al., 2015; Oliver et al., 2016). This conclusion was made from two different RCTs
carried out in Washington State and New York City (Golden et al., 2015; Oliver et al., 2016).
The researchers also found that such programs are sustainable and could be applied to local
health departments in other states (Golden et al., 2015; Oliver et al., 2016).
State legislation and explicit institutional policies and guidelines regarding EPT can
promote knowledge and awareness of EPT and subsequent use among clinicians (Pfennig, 2019;
Rosenfeld et al., 2016). This was determined through an online survey on HCPs and from an
expert opinion report (Pfennig, 2019; Rosenfeld et al., 2016). Since EPT is legal in most states
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and permissible in many, health institutions should have clear policies regarding EPT to promote
its use among clinicians.
Current CDC guidelines recommend EPT use for heterosexual women and men and not
for men who have sex with men (MSM) to treat gonorrhea and chlamydia (CDC, 2019).
However, EPT can be used among gay, bisexual, men who have sex with men (GBMSM) as a
prevention strategy as well as to decrease the rate of STIs among these populations (Clark et al.,
2017; Gamarel et al., 2019). These results were obtained from an RCT in Peru and a descriptive
study that used a small convenience sample. A mixed method study from the Netherlands found
other facilitators for increasing knowledge of EPT and its use include, providing home-based test
kits, enabling providers to contact the patient by phone, allocating more time to providers for
counseling, and providing more training to providers (Nanhoe et al., 2018).
Barriers to EPT Use
Lack of knowledge and awareness among pharmacists and pharmacy staff was the main
barrier to EPT use (Borchardt et al., 2018; Qin et al., 2018). This was determined through a
cross-sectional study in Milwaukee (Borchardt et al., 2018) and a descriptive study that was done
in Baltimore, Maryland (Qin et al., 2018). Researchers found that 58% of the nameless EPT
prescriptions were refused by pharmacies because of a lack of awareness of EPT (Borchardt et
al., 2018). Increasing awareness among pharmacists and pharmacy staff can promote EPT use
(Borchardt et al., 2018; Qin et al., 2018).
Structural concerns (insurance and transportation) or limited accessibility to pharmacies,
and differences in medication prices limit the use of EPT (Garamel et al., 2019; Qin et al., 2018).
These concerns among patients need to be addressed in order to increase EPT utilization. A
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public health EPT program which makes EPT accessible to HCPs can address this barrier as well
(Golden et al., 2015; Oliver et al., 2016).
Barriers such as prescriber’s legal responsibility, potential medication side effects, and
barriers to privacy also hinder EPT use (Garamel et al., 2019; Wood et al., 2018). These results
are based on descriptive studies that were carried out in the United States and Australia (Garamel
et al., 2019; Nanhoe et al., 2018; Wood et al., 2018). According to Nanhoe et al. (2018),
allocating more time for HCP counseling, enabling HCPs to communicate with the patient’s
partner by phone, and educating HCPs on the legal aspects of EPT will address this barrier.
Another barrier is the lack of legislation regarding EPT, this is evidenced by lack of clear
policies on EPT in the Department of Defense (DoD) and the emergency department (ED)
(Pfennig, 2019; Stidham et al., 2015). The clinicians who practice in these settings are not able to
utilize EPT (Pfennig, 2019; Stidham et al., 2015). Therefore, clear organizational policies will
enable the clinicians to utilize EPT as an additional measure to curb increasing STI rates.
Study limitations
There are some limitations in several of the studies. Borchardt et al. (2018) noted that the
customers requested to speak directly with the pharmacist, and this excludes the pharmacy
technician. The implication is that the refusal rate for EPT prescriptions could be higher since
pharmacy technicians may have less knowledge of EPT when compared to pharmacists
(Borchardt et al., 2018). Nanhoe et al. (2018) noted a limitation whereby all the participants had
special interest in STIs; therefore, their responses could have been biased toward the subject.
However, this can also be seen as a strength because the participants have expertise in
legislation, policies, and treatment of STIs (Nanhoe et al., 2018). It was also noted that recall
bias could influence the self-reported information by supervising pharmacists or the pharmacist
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on staff in the study on pharmacy level barriers that was done in Baltimore, Maryland (Qin et al.,
2018). Finally, results from this study cannot be generalizable to an area with lower STI burden
(Qin et al., 2018).
Summary
The rates of treatable STIs in the United States continue to rise despite the fact that EPT
has been established as an option to treat partners and prevent reinfection from STIs (CDC,
2019). Based on the review of the literature, some of the facilitators for EPT use include a public
health program that provides free EPT which is accessible to HCPs (Golden et al., 2015; Oliver
et al., 2016), state legislation and clear organizational policies (Rosenfeld et al., 2016), and
allocating time for providers to do counseling (Nanhoe et al., 2018). The main barriers for EPT
use are lack of knowledge and awareness of EPT guidelines among clinicians, pharmacists and
pharmacy staff (Borchardt et al., 2018; Qin et al., 2018) and lack of explicit organizational
policies on EPT (Pfennig, 2019; Stidham et al., 2015). Taking advantage of the facilitators and
overcoming these barriers will increase awareness of EPT enhance its utilization.
Evidence-based Practice
The literature review revealed that expedited partner therapy is not widely used due to
lack of knowledge and awareness of the various aspects of EPT. Therefore, through the quality
improvement (QI) project, the Doctor of Nursing Practice (DNP) student aimed to address the
gap in knowledge and practice by implementing an education intervention among clinicians to
increase awareness of EPT. The educational intervention addressed the general knowledge of
EPT, the legal aspects, institutional policies, prescription procedures, pharmacy concerns, and
patient counseling.

12
Theoretical Framework
Roger’s Diffusion of Innovation Theory emphasizes that an idea diffuses through a
specific population and in the end, it is adopted resulting in a change in behavior (LaMorte,
2019). According to the theory, LaMorte (2019) demonstrates that very few people are
innovators, about one quarter of the population are early adopters, majority of the adopters lie in
the middle of the curve, and about one quarter of the group are usually laggards. This is depicted
in the diagram in Appendix A. The innovators are the first to try anything new and they are ready
to take risks; early adopters enjoy leadership roles, they are aware of the need for change and
have no problem trying new ideas (LaMorte, 2019). The early majority are rarely leaders, they
usually need to see evidence that something works before they can try it while the late majority
are skeptical and will only adopt an idea after it has been adopted by the majority (LaMorte,
2019). Laggards are very conservative and very skeptical and sometimes it may take pressure
from other adopters for them to agree with the new idea (LaMorte, 2019).
According to LaMorte (2019), factors that will affect the process of adopting a new idea
include relative advantage (is it better than the current idea?), compatibility (is it consistent with
current values?), complexity (how easily it can be adopted), trialability (can it be tested before
committing to adopt?), and observability (can the results be measured?). EPT measures up to
these factors and can be easily adopted because, it is an additional resource to STI management;
it is compatible with the values of STI treatment; it is not complex to adopt; it can be tried by a
few HCPs before being adopted by the rest of the team; and the results can be measured by the
number of clinicians who embrace the practice in the clinic. Based on Roger’s theory of
Diffusion of Innovation, increasing awareness of EPT among clinicians in a community health
clinic will lead to a few adopting the idea initially, but over time majority will adopt it resulting
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in comprehensive EPT knowledge and use within the health center. Eventually, the idea can be
adopted by other clinics and health care centers.
Methods
Online pre/post-surveys were the main tools for collecting data for the QI project. The
education intervention was in the form of PowerPoint presentation on EPT. The main method of
data collection was quantitative. There was a general comments section at the end of the postsurvey which would generate qualitative data.
Goals, objectives, and outcomes
The goal of the DNP project was to increase knowledge and awareness and create a change in
attitude regarding EPT among providers. To achieve the goal, an evidence-based educational
quality improvement project on EPT was implemented and evaluated among providers. This
included an online pre/post intervention survey which is available in Appendix C. Also, an
education intervention in form of a PowerPoint presentation was provided so that the HCPs were
able to access it at their own convenient time. The link for the PowerPoint is attached in
Appendix D. The objectives and expected outcomes are outlined in the table below.

Objective

Expected Outcome

-A 10-minute online pre-survey would be
made available for clinicians during the
months of February 2021
- 15-minute educational presentations in form
of PowerPoint would be made available
online during the months of February 2021
for clinicians to access and review at their
own convenience
-A 10-minute online survey would be made
available to clinicians during the months of
February to March 2021

-At least 85% of the clinicians would
complete the online survey
- At least 85% of the clinicians would
access and review the PowerPoint
presentations on EPT

-At least 85% of the clinicians would
complete the post-intervention survey
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Project Site and Population
The project was implemented at a federally qualified health center (FQHC) in the
Northeast. The health centers provide primary care services including preventive services and
management of chronic conditions; women health services; mental health services which include
substance use disorders, and urgent care services to underserved communities in the area. These
communities have limited access to preventive health services and the residents tend to have
higher rates of many chronic medical conditions and STIs.
The QI project targeted clinicians from different areas of specialization including family
practice (FP), internal medicine (IM), obstetrics/gynecology (Ob/Gyn), and pediatrics.
Physicians, nurse practitioners, and physician assistants were involved in the project. The
expected outcome was increase in knowledge and awareness of EPT among clinicians.
Measurement Instruments
In order to measure the outcomes of the QI project, an online survey was administered
via SurveyMonkey. The survey was formulated to collect information on the clinician’s
demographics, knowledge of EPT, utilization of EPT, barriers, and facilitators for EPT use. The
survey was adopted from an established tool that was previously used in a qualitative study in
Pittsburgh, Pennsylvania (PA) to determine the perspectives of HCPs on EPT for chlamydia
(Rosenfeld et al., 2016).
Prior to using the survey in the study in Pittsburgh, it was reviewed by two experts in STI
testing and five public health researchers, in addition, the survey was piloted on two HCPs to
assess its clarity (Rosenfeld et al., 2016). The tool has a high sensitivity rate because the
surveyor can use it to successfully determine the knowledge, use, barriers, and facilitators for
EPT use among clinicians. In addition, the tool has a favorable specificity rate because it can also
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clearly identify the clinicians with limited knowledge and use of EPT. Therefore, this tool is
considered valid. Permission to use the survey tool for this QI project was obtained through an
online request (Appendix B).
Implementation Plan/Procedure
Participants were informed of the intended project during a staff meeting and an email
was sent to the potential participants. A pre-intervention online survey was distributed via
SurveyMonkey to the clinicians, and it was available for a period of one month. The education
intervention was made available one week after completing the presurvey and was accessible for
review over one month. A post-intervention online survey was sent via SurveyMonkey two
weeks after the pre-survey, and it was available for period of four weeks.
Knowledge of EPT was assessed using True/False/I don’t know statements. Most of the
other responses were on a five-point Likert scale with the following items: strongly agree, agree,
neutral, disagree, and strongly disagree. Baseline information on knowledge and utilization of
EPT was collected before the intervention and this was available for four weeks with a weekly
automated reminder sent out for those who hadn’t completed it. The PowerPoint presentation,
located in Appendix D, was made available one week after the pre-survey was sent out. The
PowerPoint presentation was available for four weeks for review by HCPs. Thereafter, at four
weeks post-intervention, the survey was available via SurveyMonkey to be completed by the
HCPs to determine the effectiveness of the intervention (Appendix C).
Data Collection Procedures
An online survey was administered to HCPs at two locations of a federally qualified
health center (FQHC) in Maryland. The DNP student used SurveyMonkey to administer the
survey that collected data on demographics, knowledge of EPT, barriers, facilitators, and EPT
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use. The post-survey that was used can be located under Appendix C. An interactive presentation
was not possible as previously intended and planned due to conflicting schedules and many
competing priorities resulting from the current COVID 19 pandemic.
Data Analysis
The IBM Statistical Package for the Social Sciences (SPSS) software version 27.0 was
used for data analysis. This software has been used and proven effective in analyzing trends and
determining conclusions in various projects and research studies (Gardner, 2020). Wilcoxon
signed-rank test, a non-parametric statistic, was used to compare responses to the pre/post survey
and to determine relationships. Descriptive statistics were used to compute frequencies.
Cost-Benefit Analysis
Majority of the cost for this project was in the form of time (donated time) spent by the
DNP student on the pre/post-intervention surveys, creating a PowerPoint presentation on EPT for
clinicians, and collecting and analyzing the data. The time was in form of donated time since it
was part of the coursework for the DNP student. There was no monetary cost incurred since
everything was online. A detailed table of the cost-benefit analysis can be located at Appendix E.
The benefits of the QI project include an increased knowledge and awareness of EPT among
clinicians at the community health clinic, and consequently improvement in EPT use in the
future to address STI management.
Ethical considerations and Protection of Human Subjects
The project was approved by the leadership at the site on 10/9/2020 but the letter of
support was issued two months later, the late approval was due to the current pandemic and new
projects being placed on hold. The University of Massachusetts, Amherst, Internal Review Board
(UMass IRB) approval was obtained prior to initiating the DNP project (Appendix F). A delay in
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obtaining a letter of approval resulted in a delay in the project implementation. The project
involved clinicians who completed online surveys regarding EPT. They also participated in the
PowerPoint presentation. Prior to conducting the surveys, consent (Appendix G) was obtained
from the clinicians and this was included at the beginning of the survey. The consent also
provided detailed instructions of what the survey involved.
There were no risks associated with participation in the QI project, and the responses to
the survey were made anonymous to maintain the confidentiality of the clinicians. This is in
accordance with HIPAA rules of privacy and confidentiality. The DNP student was in charge of
the storage, retrieval and safeguarding of all data and survey responses for the project.
Information was coded using random individual identification numbers to maintain anonymity.
The report from the QI project was kept in online electronic files which were accessible by a
password and there was no individual identifiable information. During analysis, the data obtained
from the survey responses was coded using random individual identification numbers to maintain
anonymity.
Results
The purpose of the project was to increase knowledge and awareness of expedited partner
therapy among providers. The project was carried out at two locations of a FQHC in Maryland.
Twelve clinicians participated in the pre-survey and seven in the post-survey. The participation
goal was 85% which translates to 15 out of the target of 20 participants, but in this project, 60%
(12 out of 20) participated in the presurvey and only 35% (7 out of 20) participated in the postsurvey. The project involved a pre-survey, education intervention, and post survey. The
clinicians had varying years of experience from less than five to more than 20 years of practice,
they were from different specialties, and majority of them were female.
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Results based on frequency distribution indicate that all the participants agreed that
concern about medication allergies was the main barrier for EPT use. Also, 58% of the presurvey
and 71% postsurvey participants agree that liability was another barrier, and this is closely
related to medication allergies. Surprisingly, 42% of the participants for both pre/post survey
viewed time constraint as a barrier for EPT use and the rest were either neutral on the issue or
disagreed with it. In regard to the facilitators for EPT use, 58% of the presurvey and 71% of the
postsurvey participants agreed that institutional guidelines on EPT use were important.
However, 92% of the presurvey and 85% of the postsurvey participants agreed that EPT training
was important. It was unexpected that only 42% of participants viewed time constraints to be a
barrier. These results can be located in Appendix H (Tables 3-12).
Using the Wilcoxon signed-rank test, the intervention resulted in statistically significant
results when current EPT use was compared to future plan to use EPT. However, the intervention
did not create statistically significant results when comparing the pre and post intervention
results for most of the other variables related to knowledge of EPT such as legal status,
prescription requirements, and billing for EPT. These results are shown in the table below.
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Table 1: Comparison of knowledge variables pre/post
NPAR TESTS
/WILCOXON=pre1 pre2 pre4 pre5 pre14 WITH post1 post2 post4 post5 post14 (PAIRED)
/STATISTICS DESCRIPTIVES /MISSING ANALYSIS.

The Wilcoxon signed-rank test result was (p = 0.042, Z= -2.032) with a confidence interval (CI)
of 95%, these results are statistically significant, meaning there was a change in attitude toward
EPT use as a result of the education intervention.
Based on the statistical analysis using Wilcoxon signed-rank test, the variables that
represent facilitators and barriers in Table 2 below did not have significant results when a
comparison was done before and after the intervention.
Table 2: Comparison of variables related to facilitators and barriers pre/post
NPAR TESTS /WILCOXON=pre8 pre9 pre10 pre11 pre12 WITH post8 post9 post10 post11 post12 (PAIRED)

/STATISTICS DESCRIPTIVES QUARTILES /MISSING ANALYSIS.
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The above results indicate that the clinicians’ views towards the facilitators and barriers for EPT
use preintervention compared to post-intervention do not have much impact on the use of EPT.
Discussion
The results from the project strongly imply that an increase in knowledge and awareness
of EPT among providers will result in increased use of EPT. This is supported by the outcome of
the project which indicate that the education intervention resulted in a change in attitude toward
EPT use. Using the Wilcoxon signed rank test for statistical analysis the results were (p = 0.042),
which can be interpreted that as a result of the project, more clinicians planned to use EPT.
Therefore, the results from the project confirm the literature findings which concluded that
increase in knowledge and awareness of EPT is one way to improve its use.
In relation to Roger’s Diffusion of Innovation Theory, there were a few innovators who
were already using EPT before the project was initiated. When the other clinicians learned about
it, they got interested in the idea of EPT use and by the end of the brief project, more clinicians
became adopters. Early and late majority clinicians who were hesitant and only committed to
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rarely use EPT due to other influencing factors such as liability. However, as EPT use becomes
widespread in the entire organization, it is predicted that they will adopt the practice. Laggards
are the clinicians who will be last to adopt the new practice when it becomes common practice in
the organization.
Barriers and facilitators that may influence EPT use need to be controlled even though
the results for these variables were not statistically significant in this project. The outcome was
not significant likely because the sample was small. The facilitators for EPT use such as having
clear institutional guidelines and training on its use should be addressed. Training will provide a
common and clear understanding on how to prescribe and dispense EPT, and clear policy and
guidelines will address any liability concerns that may arise. The three main barriers for EPT use
include a concern about medication allergies and possible interactions, liability associated with
treating a patient who is not known to the provider, and time constraints.
The concern about medication allergies implies that it is challenging for a clinician to
prescribe medications to a patient when the allergies are unknown or the interaction that may
occur with that patient’s current medications. Liability was the other barrier which is closely
related to the medication allergies and refers to the provider not knowing the recipient’s medical
history, current medications, and medication allergies. Therefore, in case of any allergic reaction,
the provider may be liable because of providing a prescription without adequate assessment.
Time constraints play a role because additional time not allocated in the clinician’s schedule may
be needed to prescribe and provide any necessary education materials for partner review.
Project Limitations
The competing priorities and time constraints which have been heightened by the
pandemic were evident during project implementation, and this led to the low number of
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participants for the project. Also, the planned interactive education intervention was not possible
due to conflicts in clinician schedules and various competing priorities stated earlier. These may
have impacted the results for most variables that may influence EPT use not being statistically
significant, the small sample size may have affected the results of the project as well. Despite the
limitations, a facilitator for the project was the fact that EPT was not a totally new idea and some
of the clinicians were using it in their current practice. Therefore, future studies can use a more
interactive intervention and a larger sample to determine if the results will be of statistical
significance.
Conclusion
In summary, the project showed that increased knowledge and awareness of EPT among
HCPs will result in improved use of EPT for better management of STIs. In addition to
increasing awareness and knowledge of EPT, the following factors need to be addressed, having
clear organizational policies on EPT, addressing the barriers such as liability, medication allergy
concerns, and time constraints for clinicians. Despite the unforeseen and unexpected challenges,
it is clear that increasing knowledge and awareness on EPT can result in enhanced EPT use
among clinicians. Although the results from this project cannot be generalized to other settings,
they can serve as a foundation or starting point for future studies. Furthermore, I would
recommend that future studies include larger sample sizes and improve on the techniques of
presenting the intervention to the providers. These may help to affirm current findings or prove
otherwise and also to determine the significance of the other factors.
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Appendix A: Theoretical Framework
Diffusion of Innovation Theory

Image by Jurgen Appelo, Flickr, downloaded 12/5/2016, https://flic.kr/p/8VBTUM
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Appendix B: Permission for Survey
The link to the permission obtained to use the survey tool which is included in the article.
file:///Users/angelinemotari/Desktop/Rightslink® by Copyright Clearance
Center.webarchive
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Appendix C: Measurement
Pre/post-intervention Survey
Part 1: Demographics
Demographics
Age in years
<30
30-49
50+
Gender:
Male
Female
Specialty:
Family Practice
Internal Medicine
Obstetrics/Gynecology
Pediatrics
Average number of patients per week
1-10
11-20
20+
Years in practice
<5
5-10
10-15
15+

Response
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Part 2: Expedited Partner Therapy Pre/Posttest
1. Expedited partner therapy (EPT) is legal in 45 states and the District of Columbia. True
or False or I don’t know
2. Expedited partner therapy was recommended by the Centers for Disease Control and
Prevention (CDC) in 2010. True or False or I don’t know
3. Expedited partner therapy is legal in Maryland. True or False or I don’t know
4. My clinic has a policy on EPT. True or False or I don’t know
5. The following describes the eligibility criteria for Expedited partner therapy. Select ALL
that apply
a. Sex partners within the past 60 days prior to diagnosis
b. Pregnant women
c. Only one partner is eligible
d. No limit to the number of partners
6. If the partner’s name is unknown, “EPT” is sufficient on the prescription. True or False
or I don’t know
7. The patient’s insurance can be billed for Expedited partner therapy. True or False or I
don’t know
8. “EPT” or “Expedited Partner Therapy” must be included in the prescription. True or
False or I don’t know
The following statements are meant to assess barriers and facilitators for expedited
partner therapy using a Likert scale of 1-5 with 1= strongly disagree and 5 = strongly
agree
9. Prescribing treatment for Sexually Transmitted Infections for a sexual partner(s) who is
not your patient(s). 1. Strongly disagree 2. Disagree 3. Neutral 4. Agree 5. Strongly
agree
10. Knowledge about institutional guidelines is important in EPT use. 1. Strongly disagree
2. Disagree 3. Neutral 4. Agree 5. Strongly agree
11. Training on how to provide EPT is an important factor. 1. Strongly disagree 2. Disagree
3. Neutral 4. Agree 5. Strongly agree
12. Time constraint is a factor in deciding whether or not to use EPT. 1. Strongly disagree 2.
Disagree 3. Neutral 4. Agree 5. Strongly agree
13. Knowledge about intimate partner violence is important when deciding whether or not to
prescribe EPT. 1. Strongly disagree 2. Disagree 3. Neutral 4. Agree 5. Strongly agree
14. Liability is a concern when you plan to use EPT. 1. Strongly disagree 2. Disagree 3.
Neutral 4. Agree 5. Strongly agree
15. Medication allergies are a concern when prescribing EPT. 1. Strongly disagree 2.
Disagree 3. Neutral 4. Agree 5. Strongly agree
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This last question assesses the likelihood of expedited partner therapy use on a Likert
scale of 1-5 with 1= Never and 5 = Always
16. On a scale of 1-5 how likely are you to use EPT? 1. Never 2. Rarely 3. Sometimes 4.
Often 5. Always
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Appendix D: Education Intervention
PowerPoint (PP) presentation can be found in the links below
https://umassmy.sharepoint.com/:p:/g/personal/amotari_umass_edu/EdIxFpqhU0REmuwWCGomEJIBUW1d
1NP4Zuf3Thte9R1y5g?e=kKBMQh
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Appendix E: Cost-Benefit Analysis
Estimated cost of the QI project will be in form of donated time provided in kind by the DNP
student:
Compiling the online survey: 4 hours x $ 60 / hour = $240
Development of a PowerPoint presentation: 4 hours x $ 60 / hour = $240
Data collection: (20hrs/month x1 month) = 20 hours x $ 60 / hour = $1200
Data Analysis: (5 hours/day x7 days) = 35 hours x $60 / hour = $2100
Presentation of the results: 2 hours x $ 60 / hour = $120
Total cost = $3,900
There was no monetary cost associated with this project since the project was entirely online.
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Appendix F: UMass IRB Approval

file:///Users/angelinemotari/Downloads/UMass_IRBApproval_Motari.pdf
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Appendix G: Consent Form
You are being invited to participate in a quality improvement (QI) project titled, “Increasing

Knowledge and Awareness of Expedited Partner Therapy among Providers”. This QI project is
being done by Angeline K. Motari, DNP student from the University of Massachusetts, Amherst. The
purpose of this project is to increase knowledge and awareness of expedited partner therapy (EPT) among
providers and create a change in attitude among providers regarding EPT. If you agree to participate in
the project, you will be asked to complete an online survey/questionnaire (pre-survey), also participate in
an education intervention regarding EPT, and then a post-survey.
By clicking agree below, you are indicating that you are at least 18 years old, have read and understand
the consent form and you agree to participate in the quality improvement project.
o

I agree to terms and conditions

o

I disagree
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Appendix H: Frequency Tables

Table 3: Presurvey

Table 4: Post-survey

Table 5: Presurvey

Table 6: Post-survey

Table 7: Presurvey

Table 8: Post-survey

Table 9: Presurvey

Table 11: Presurvey

Table 10: Postsurvey

Table 12: Postsurvey

